Madeline Deutsch, MD

Primary care specialist

Dr. Madeline Deutsch specializes in providing primary care for gender and sexual minorities, including those from the transgender, gender non-binary, gay, lesbian, bisexual and queer communities. She is the director of UCSF Transgender Care and specializes in managing gender-affirming hormone therapy. Other areas of interest include contraception management and working with patients who have coexisting mental health conditions.

Deutsch has a special interest in disease prevention, dietary and lifestyle approaches to improve health outcomes, and integrative medicine. She believes in practicing a patient-centered, collaborative and individualized approach to prevention and care.

Deutsch earned a medical degree at the Chicago Medical School at Rosalind Franklin University, followed by a residency at Harbor-UCLA Medical Center. She also received a master's degree in public health from UCLA, and is certified as an HIV expert by the American Academy of HIV Medicine.

Deutsch has an active research portfolio, which includes the study of HIV pre-exposure prophylaxis (PrEP), the use of electronic medical records to capture gender identity and sexual orientation data, and screening for cancer and sexual health risks in transgender populations. She has produced more than 25 publications on gender and sexual minority health topics and serves as an associate editor for the journal LGBT Health.

This doctor is accepting new patients


Women's Health Primary Care
2356 Sutter St., Third and Fourth Floors
San Francisco, CA 94143
New Patient Appointments:
(844) 727-8273 (PCP-UCSF)
Office: (415) 885-7788
Fax: (415) 353-2494

Hours: Monday to Friday
8 a.m. – 5 p.m.

Board Certification

Emergency Medicine, American Board of Emergency Medicine

Academic Title

Associate Professor

More about Madeline Deutsch

Additional Languages



Chicago Medical School at Rosalind Franklin University 2001

Selected Research and Publications

  1. Deutsch MB, Radix A, Wesp L. Breast Cancer Screening, Management, and a Review of Case Study Literature in Transgender Populations. Semin Reprod Med. 2017 Sep; 35(5):434-441.
  2. Reisner SL, Deutsch MB, Peitzmeier SM, White Hughto JM, Cavanaugh T, Pardee DJ, McLean S, Marrow EJ, Mimiaga MJ, Panther L, Gelman M, Green J, Potter J. Comparing self- and provider-collected swabbing for HPV DNA testing in female-to-male transgender adult patients: a mixed-methods biobehavioral study protocol. BMC Infect Dis. 2017 Jun 23; 17(1):444.
  3. Braun HM, Garcia-Grossman IR, Quiñones-Rivera A, Deutsch MB. Outcome and Impact Evaluation of a Transgender Health Course for Health Profession Students. LGBT Health. 2017 Feb; 4(1):55-61.
  4. Vance SR, Deutsch MB, Rosenthal SM, Buckelew SM. Enhancing Pediatric Trainees' and Students' Knowledge in Providing Care to Transgender Youth. J Adolesc Health. 2017 Apr; 60(4):425-430.
  5. Wesp LM, Deutsch MB. Hormonal and Surgical Treatment Options for Transgender Women and Transfeminine Spectrum Persons. Psychiatr Clin North Am. 2017 Mar; 40(1):99-111.
  6. Deutsch MB, Radix A, Reisner S. What's in a Guideline? Developing Collaborative and Sound Research Designs that Substantiate Best Practice Recommendations for Transgender Health Care. AMA J Ethics. 2016 Nov 01; 18(11):1098-1106.
  7. Sevelius JM, Deutsch MB, Grant R. The future of PrEP among transgender women: the critical role of gender affirmation in research and clinical practices. J Int AIDS Soc. 2016; 19(7(Suppl 6)):21105.
  8. Grant RM, Sevelius JM, Guanira JV, Aguilar JV, Chariyalertsak S, Deutsch MB. Transgender Women in Clinical Trials of Pre-Exposure Prophylaxis. J Acquir Immune Defic Syndr. 2016 Aug 15; 72 Suppl 3:S226-9.
  9. Reisner SL, Radix A, Deutsch MB. Integrated and Gender-Affirming Transgender Clinical Care and Research. J Acquir Immune Defic Syndr. 2016 Aug 15; 72 Suppl 3:S235-42.
  10. Radix A, Sevelius J, Deutsch MB. Transgender women, hormonal therapy and HIV treatment: a comprehensive review of the literature and recommendations for best practices. J Int AIDS Soc. 2016; 19(3 Suppl 2):20810.
  11. Cahill SR, Baker K, Deutsch MB, Keatley J, Makadon HJ. Response to Dr. Thompson and Colleagues. LGBT Health. 2016 Aug; 3(4):321-3.
  12. Deutsch MB. Making It Count: Improving Estimates of the Size of Transgender and Gender Nonconforming Populations. LGBT Health. 2016 Jun; 3(3):181-5.
  13. Sevelius J, Deutsch MB, Glidden DV, Grant RM. PrEP adherence among trans women in Brazil-access needed for this key population - Authors' reply. Lancet HIV. 2016 May; 3(5):e200-1.
  14. Feldman J, Brown GR, Deutsch MB, Hembree W, Meyer W, Meyer-Bahlburg HF, Tangpricha V, T'Sjoen G, Safer JD. Priorities for transgender medical and healthcare research. Curr Opin Endocrinol Diabetes Obes. 2016 Apr; 23(2):180-7.
  15. Reisner SL, Deutsch MB, Bhasin S, Bockting W, Brown GR, Feldman J, Garofalo R, Kreukels B, Radix A, Safer JD, Tangpricha V, T'Sjoen G, Goodman M. Advancing methods for US transgender health research. Curr Opin Endocrinol Diabetes Obes. 2016 Apr; 23(2):198-207.
  16. Bockting W, Coleman E, Deutsch MB, Guillamon A, Meyer I, Meyer W, Reisner S, Sevelius J, Ettner R. Adult development and quality of life of transgender and gender nonconforming people. Curr Opin Endocrinol Diabetes Obes. 2016 Apr; 23(2):188-97.
  17. Deutsch MB. Evaluation of Patient-Oriented, Internet-Based Information on Gender-Affirming Hormone Treatments. LGBT Health. 2016 Jun; 3(3):200-7.
  18. Deutsch MB. Gender-affirming Surgeries in the Era of Insurance Coverage: Developing a Framework for Psychosocial Support and Care Navigation in the Perioperative Period. J Health Care Poor Underserved. 2016; 27(2):386-91.
  19. Cahill SR, Baker K, Deutsch MB, Keatley J, Makadon HJ. Inclusion of Sexual Orientation and Gender Identity in Stage 3 Meaningful Use Guidelines: A Huge Step Forward for LGBT Health. LGBT Health. 2016 Apr; 3(2):100-2.
  20. Deutsch MB, Glidden DV, Sevelius J, Keatley J, McMahan V, Guanira J, Kallas EG, Chariyalertsak S, Grant RM. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial. Lancet HIV. 2015 Dec; 2(12):e512-9.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.